Related Experiment Video

Updated: May 24, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

DNA methylation in promoter region as biomarkers in prostate cancer

Mihi Yang1, Jong Y Park

  • 1Division of Cancer Prevention and Controls, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Methods in Molecular Biology (Clifton, N.J.)
|February 24, 2012
PubMed

Insights

Epigenetic alterations, specifically DNA methylation in gene promoter regions, are linked to prostate cancer development and progression. These changes offer potential biomarkers and therapeutic targets for personalized prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Prostate cancer is a leading cause of cancer death in American men.
  • Epigenetic alterations, including DNA methylation, are implicated in cancer development.
  • Gene promoter hypermethylation can lead to transcriptional silencing in cancer cells.

Purpose of the Study:

  • To review current knowledge on methylated genes in prostate cancer.
  • To explore the role of these methylated genes in critical cellular pathways.
  • To highlight the potential of epigenetic alterations as biomarkers and therapeutic targets.

Main Methods:

  • Review of scientific literature on gene promoter methylation in prostate cancer.
  • Analysis of over 40 investigated methylated genes.
  • Discussion of the involvement of these genes in DNA repair, metabolism, and invasion/metastasis pathways.

Main Results:

  • Over 40 genes have been identified with promoter hypermethylation in prostate cancer.
  • These methylated genes are involved in key pathways crucial for cancer progression.
  • Hypermethylation plays a significant role in regulating these critical pathways.

Conclusions:

  • Methylated genes in prostate cancer offer insights into pathogenesis.
  • Epigenetic alterations show potential as predictive biomarkers for personalized treatment.
  • Some epigenetic modifications are already being integrated into clinical practice for prostate cancer therapy.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...